Global Hematology Diagnostics Market to Exceed $5.2 Billion by 2026 - ResearchAndMarkets.com

DUBLIN--()--The "Global Hematology Diagnostics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018-2026" report has been added to ResearchAndMarkets.com's offering.

The hematology diagnostics market was valued at US$ 3,167.2 million in 2017 and expected to reach US$ 5,288.3 million by 2026 at a CAGR of 5.9% during the forecast period from 2018 to 2026.

Key Market Movements

  • Globally, the hematology diagnostics market is growing at a CAGR of 5.9% for the period from 2018 to 2026
  • Based on the product type, the hematology analyzer segment shows lucrative growth with enhanced applications in the diagnostics industry
  • An increasing number of diagnostic centers, availability of automated analyzers with enhanced applications, and increasing test volumes will contribute to the overall growth of the hematology diagnostics market
  • Major players in this vertical are Abbott Laboratories, Bio-Rad Laboratories, Inc., Siemens Healthineers, Mindray Medical International Limited, Danaher Corporation, Hoffmann-La Roche Ltd., Nihon Kohden Corporation, Drew Scientific, Sysmex Corporation, EKF Diagnostics, Boule Diagnostics, HORIBA, Diatron MI Zrt. and others.

Market Insights

The global hematology diagnostics market is growing significantly due to the rising prevalence of blood-related disorders, cancer, and infectious diseases. Additionally, increasing awareness of these targeted diseases along with its diagnosis and screening by diagnostic centers, hospitals, private firms, and social media are the key factors driving the market growth internationally. Currently, more than 1.3 million individuals in the U.S. are living with leukemia, myeloma or lymphoma.

Hematology consumables hold the major share in the hematology diagnostics market in 2017. New product launch, acquisitions, and partnerships among top players in the developed nations are factors promoting market growth. For instance, in June 2017, Abbott Laboratories declared the availability of CP3000 coagulation analyzer by Sekisui Diagnostics in the Asia Pacific, Europe, and the Middle East. Moreover, in April 2018, Danaher Corporation received CE Mark approval of its DxH 520 hematology analyzer.

Hematology testing products has gained extensive acceptance worldwide mainly by hospitals and diagnostic centers. Demand for automated hematology instruments in the emerging nations is gaining traction slowly along with enhanced diagnosis services. Limited availability of new products, less awareness regarding blood disorders and unstructured medical care in developing nations will restrain market growth globally. However, enhanced productivity of test results via automation techniques along with flow cytometers and sales of hematology instruments with high throughput screening will drive the market growth during the forecast period.

The market in the Asia Pacific shows promising growth due to new technology expansion along with government funding. Moreover, increasing prevalence of blood disorders, demand for point of care services and boom in the biotechnology industry are key factors driving the overall market growth.

Key Topics Covered

Chapter 1. Preface

1.1. Report Description

1.2. Market Segmentation

1.3. Research Scope

1.4. Research Methodology

1.5. Market Segmentation

Chapter 2. Executive Summary

2.1. Global Hematology Diagnostics Market Portraiture

2.2. Global Hematology Diagnostics Market, by Product Type, 2017 (US$ Mn)

2.3. Global Hematology Diagnostics Market, by End User, 2017 (US$ Mn)

2.4. Global Hematology Diagnostics Market, by Geography, 2017 (US$ Mn)

Chapter 3. Global Hematology Diagnostics Market: Market Dynamics and Future Outlook

3.1. Market Overview

3.2. Hematology Diagnostics Technologies: Future Trends

3.3. Current Scenario: Partnerships, Mergers & New Product Launches

3.4. Drivers

3.5. Challenges

3.6. Opportunities

3.7. Attractive Investment Proposition, by Geography, 2017

3.8. Competitive Landscape, by Key Players, 2017

Chapter 4. Global Hematology Diagnostics Market, by Product Type, 2016-2026 (US$ Mn)

4.1. Overview

4.2. Hematology Instruments

4.2.1. Hematology Analyzers

4.2.2. Flow Cytometers

4.2.3. Others

4.3. Hematology Consumables

4.3.1. Reagents

4.3.2. Stains

4.3.3. Controls & Calibrators

4.3.4. Others

Chapter 5. Global Hematology Diagnostics Market, by End User, 2016-2026 (US$ Mn)

5.1. Overview

5.2. Diagnostic Laboratories

5.3. Hospitals & Clinics

5.4. Academic and Research Institutes

Chapter 6. Global Hematology Diagnostics Market, by Geography, 2016-2026 (US$ Mn)

6.1. Overview

6.2. North America Hematology Diagnostics Market Analysis, 2016-2026

6.2.1. North America Hematology Diagnostics Market, by Product Type, 2016-2026 (US$ Mn)

6.2.2. North America Hematology Diagnostics Market, by End User, 2016-2026 (US$ Mn)

6.2.3. North America Hematology Diagnostics Market, by Country, 2016-2026 (US$ Mn)

6.2.3.1. U.S.

6.2.3.2. Canada

6.3. Europe Hematology Diagnostics Market Analysis, 2016-2026

6.4. Asia Pacific Hematology Diagnostics Market Analysis, 2016-2026

6.5. Latin America Hematology Diagnostics Market Analysis, 2016-2026

6.6. Middle East & Africa (MEA) Hematology Diagnostics Market Analysis, 2016-2026

Chapter 7. Company Profiles

7.1. Abbott Laboratories

7.1.1. Business Description

7.1.2. Financial Information (Subject to data availability)

7.1.3. Product Portfolio

7.1.4. Key Developments

7.2. Bio-Rad Laboratories Inc.

7.3. Siemens Healthineers

7.4. Mindray Medical International Limited

7.5. F. Hoffmann-La Roche Ltd.

7.6. Danaher Corporation

7.7. Nihon Kohden Corporation

7.8. Drew Scientific

7.9. Sysmex Corporation

7.10. EKF Diagnostics

7.11. Boule Diagnostics

7.12. HORIBA

7.13. Diatron MI Zrt.

For more information about this report visit https://www.researchandmarkets.com/r/q7n1a0

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Hematology

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Hematology